rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2009-7-21
|
pubmed:abstractText |
Due to its safety profile and ease of oral administration, linezolid became an alternative to vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. The aim of our study was to compare bone tissue and plasma concentrations of linezolid and vancomycin in prosthesis-related MRSA infection in a rabbit model.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0031-7144
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
407-9
|
pubmed:meshHeading |
pubmed-meshheading:19618680-Acetamides,
pubmed-meshheading:19618680-Animals,
pubmed-meshheading:19618680-Anti-Infective Agents,
pubmed-meshheading:19618680-Bone and Bones,
pubmed-meshheading:19618680-Chromatography, High Pressure Liquid,
pubmed-meshheading:19618680-Methicillin-Resistant Staphylococcus aureus,
pubmed-meshheading:19618680-Oxazolidinones,
pubmed-meshheading:19618680-Prosthesis-Related Infections,
pubmed-meshheading:19618680-Rabbits,
pubmed-meshheading:19618680-Spectrophotometry, Ultraviolet,
pubmed-meshheading:19618680-Vancomycin
|
pubmed:year |
2009
|
pubmed:articleTitle |
Bone tissue and plasma concentrations of linezolid and vancomycin in rabbits with prosthesis-related infection due to MRSA.
|
pubmed:affiliation |
University Hospital of Heidelberg, Pharmacy Department, Im Neuenheimer Feld 670, 69120 Heidelberg, Germany. stefanie.swoboda@med.uni-heidelberg.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|